Metropolis Healthcare Ltd.

View in App
1442.35 -27.70 ▼-1.9%

04 October 2023, 04:01:00 PM
Volume: 8,893

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.metropolisindia.com
Market Cap 7,365.28 Cr.
Enterprise Value(EV) 7,515.56 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 27.00 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 53.26 Trailing Twelve Months Ending 2023-06
Industry PE 56.32 Trailing Twelve Months Ending 2023-06
Book Value / Share 197.16 Trailing Twelve Months Ending 2023-06
Price to Book Value 7.29 Calculated using Price: 1,437.95
Dividend Yield 0.56 Period Ending 2023-03
No. of Shares Subscribed 5.12 Cr. 51,220,706 Shares
FaceValue 2
About Metropolis Healthcare Ltd.
Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine' tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized' tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized' tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement.

Metropolis Healthcare Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Metropolis Healthcare Ltd. Performance

View details >>
1 Day
-1.88%
1 Week
+0.30%
1 Month
+5.76%
3 Month
-1.88%
6 Month
+14.73%
1 Year
-4.71%
2 Year
-48.09%
5 Year
10 Year

Metropolis Healthcare Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 18.77 26.16 36.47 30.38 30.17 27.33 30.07 27.31 15.46
Return on Capital Employed (%) 27.47 40.06 54.28 45.22 45.10 37.90 41.60 34.39 19.83
Return on Assets (%) 14.48 19.06 23.75 16.93 15.51 14.78 18.43 15.31 8.30

Metropolis Healthcare Ltd. Balance Sheet

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 361 265 323 415 419 524 707 886 988
Non Curr. Liab. 10 1 16 148 142 195 111 493 417
Curr. Liab. 75 105 152 233 241 210 240 364 303
Minority Int. 23 20 21 14 1 2 1 2 2
Equity & Liab. 468 391 512 810 803 930 1,059 1,745 1,710
Non Curr. Assets 167 166 227 367 381 492 415 1,289 1,370
Curr. Assets 302 225 285 443 422 438 645 455 341
Misc. Exp. not W/O
Total Assets 468 391 512 810 803 930 1,059 1,745 1,710

Metropolis Healthcare Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 455 524 545 647 761 856 998 1,228 1,148 1,145
Other Income 6 22 26 8 8 9 12 20 17 15
Total Income 461 546 570 655 769 865 1,010 1,248 1,166 1,161
Total Expenditure -337 -388 -391 -469 -557 -619 -708 -883 -857 -863
PBIDT 124 158 179 186 212 246 302 366 309 298
Interest -2 -2 -2 -4 -4 -13 -12 -25 -32 -25
Depreciation -21 -21 -17 -19 -20 -39 -46 -63 -89 -89
Taxation -33 -46 -53 -52 -63 -41 -61 -79 -44 -45
Exceptional Items -8 -25 16
PAT 68 82 107 112 125 128 183 215 143 139
Minority Interest -7 -8 -8 -3 0 0 -1 -1 -1
Share Associate -6 -1 -1
Other Related Items
Consolidated Net Profit 61 74 102 104 120 127 183 214 143 138
Adjusted EPS 62 77 107 109 24 25 36 42 28 27

Metropolis Healthcare Ltd. Cash Flow

View details >>
Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 102 104 90 215 249 253 247
Cash Fr. Inv. -86 2 35 -105 62 -738 47
Cash Fr. Finan. -17 -87 -118 -55 -33 163 -292
Net Change -1 19 7 55 278 -322 2
Cash & Cash Eqvt 26 43 51 107 387 66 69

Metropolis Healthcare Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 50.37 50.33 49.50 49.79 49.79 49.76 49.76 49.75 49.75
Public 49.63 49.67 50.50 50.21 50.21 50.24 50.24 50.25 50.25
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 3.30 3.30 2.67 1.18 1.18 1.18 1.18 1.18 1.18

Metropolis Healthcare Ltd. Announcements

View details >>
Fri, 29 Sep 2023
Closure of Trading Window
This is to inform you that pursuant to the Companys Code of Fair disclosure of Unpublished Price Sensitive Information framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended the trading window for dealing in Securities of the Company by the Designated Persons of the Company and/ or their immediate relatives will be closed with effect from October 01 2023 and shall remain closed up to 48 (Forty-Eight) hours after the declaration of the Financial Results of the Company for the quarter and half year ending September 30 2023. The date of the Board Meeting for approval of Financial Results of the Company for the quarter and half year ending September 2023 shall be intimated in due course.
Thu, 28 Sep 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
This is to inform you that the Company has published today an advertisement in Free Press Journal (English Newspaper) & Navshakti (Marathi Newspaper) regarding the dispatch of Postal Ballot Notice.
Wed, 27 Sep 2023
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find attached Postal Ballot Notice dated August 02 2023 seeking approval of the Members of the Company by way of remote e-voting for appointment of Mr. Subramanian Ranganathan (DIN: 00125493) as a Non-Executive Independent Director of the Company.

Metropolis Healthcare Ltd. Technical Scans

View details >>
Tue, 03 Oct 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
High Increase in 1 Month High Increase in 1 Month
Fri, 29 Sep 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Metropolis Healthcare Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 273,992.06 1,121.75 -1.8%
Divi's Laboratories Ltd. 98,792.80 3,702.05 -0.5%
Cipla Ltd. 95,478.34 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. 91,061.15 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. 73,583.24 5,048.70 -1.4%
Mankind Pharma Ltd. 72,079.88 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. 63,636.20 1,865.70 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.48 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 66.87 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 30.69 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.28 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.06 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.25 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.53 1,865.70 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.72 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 7.53 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 3.92 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.71 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.73 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.89 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.68 1,865.70 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,865.70 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,865.70 -0.8%

Metropolis Healthcare Ltd. FAQ's

What is Metropolis Health. share price?
Can I buy Metropolis Health. shares now?
What is the Dividend Yield of Metropolis Health.?
What is the Market Cap of Metropolis Health.?
What are the key metrics to analyse Metropolis Health.?
What is the 52 Week High and Low of Metropolis Health.?
What is the trend of Metropolis Health. share price?